指南与共识甲状腺与浅表介入USDSA

局部区域治疗在甲状腺疾病治疗中的作用:介入放射学会基金会研究共识专家组的会议记录

Role of Locoregional Therapies in the Treatment of Thyroid Pathology: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel.
指南 / 共识 · J Vasc Interv Radiol · 2024-08-15

介入放射学会基金会召集多学科国际研究共识专家组,聚焦甲状腺良恶性疾病局部区域治疗的文献空白,确立研究优先方向:热消融治疗甲状腺微小乳头状癌的结节特征、T1b期乳头状癌消融的I期与II期研究序列、以及>20 mL功能性结节栓塞联合消融的随机对照试验或前瞻性注册研究。

要点

  • 专家组优先建立国际注册或前瞻性多机构试验,明确与甲状腺微小乳头状癌热消融理想结局相关的结节特征(含大小和位置)。
  • 专家组优先通过两项序贯研究评估局部区域治疗在T1b期乳头状甲状腺癌中的作用:先I期消融后立即切除,再II期前瞻性多机构消融后活检。
  • 专家组优先通过随机临床试验或前瞻性注册研究,比较单纯栓塞与栓塞后消融治疗>20 mL大型功能性甲状腺结节。

核心结论

  • 专家组聚焦甲状腺局部区域治疗的文献空白,确立以结节特征、T1b期乳头状癌消融序贯研究和>20 mL功能性结节栓塞联合消融为核心的研究优先方向。

研究设计与样本

  • 介入放射学会基金会组建的多学科国际研究共识专家组会议记录,专家组成员为具有良恶性甲状腺疾病管理专长的多学科医师。

诊断标准与关键数值

  • 专家组优先方向:通过国际注册或前瞻性多机构试验,识别与甲状腺微小乳头状癌热消融理想结局相关的结节特征(包括大小和位置)。
  • 专家组优先方向:通过(a)T1b期乳头状甲状腺癌消融后立即切除的I期研究,可能推进至(b)T1b期乳头状甲状腺癌消融后活检的II期前瞻性多机构研究,评估局部区域治疗的作用。
  • 专家组优先方向:通过随机临床试验或前瞻性注册研究,比较单纯栓塞与栓塞后消融治疗体积>20 mL的大型功能性甲状腺结节。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The role of locoregional therapy in the management of thyroid pathology is rapidly evolving. The Society of Interventional Radiology (SIR) Foundation commissioned an international research consensus panel consisting of physicians from multiple disciplines with expertise in the management of benign and malignant thyroid disease. The panel focused on identifying gaps in the current body of literature to establish research priorities that have the potential to shape the landscape of minimally invasive thyroid interventions. The topics discussed were centered on the emerging role of ablation for malignant thyroid tumors and the treatment of large functioning nodules with embolization and ablation. Specifically, the panel prioritized identifying nodule characteristics, including size and location, that are associated with ideal outcomes following thermal ablation for papillary thyroid microcarcinoma through the development of an international registry or a prospective, multi-institutional trial. The panel also prioritized evaluating the role of locoregional therapy in Stage T1b papillary thyroid cancer through a sequence of 2 studies: (a) a Phase I study of ablation followed by immediate resection of Stage T1b papillary thyroid cancer, which may lead to (b) a Phase II prospective, multi-institutional study of ablation followed by biopsy for Stage T1b papillary thyroid cancer. Lastly, the panel prioritized investigating the treatment of large, functioning thyroid nodules >20 mL in volume through a randomized clinical trial or prospective registry comparing embolization alone with embolization followed by ablation.

来源:J Vasc Interv Radiol,查看原文。版权归原作者所有。

引用

  1. Lam AH, Holt E, Ridouani F, et al. Role of Locoregional Therapies in the Treatment of Thyroid Pathology: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol. 2024. PMID: 39153659. doi:10.1016/j.jvir.2024.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。